FTL Gene

FTL Gene

<div class="infobox infobox-gene">
<table>
<tr><th colspan="2" style="background:#1976D2; color:white;">FTL</th></tr>
<tr><td><strong>Full Name</strong></td><td>Ferritin Light Chain</td></tr>
<tr><td><strong>Gene Symbol</strong></td><td>FTL</td></tr>
<tr><td><strong>Chromosomal Location</strong></td><td>19q13.33</td></tr>
<tr><td><strong>NCBI Gene ID</strong></td><td>2512</td></tr>
<tr><td><strong>OMIM ID</strong></td><td>134790</td></tr>
<tr><td><strong>Ensembl ID</strong></td><td>ENSG00000196954</td></tr>
<tr><td><strong>UniProt ID</strong></td><td>P02792</td></tr>
<tr><td><strong>Protein Family</strong></td><td>Ferritin light chain subunit</td></tr>
<tr><td><strong>Associated Diseases</strong></td><td>Neuroferritinopathy, Alzheimer's Disease, Parkinson's Disease, NBIA</td></tr>
</table>
</div>

Introduction

FTL encodes the ferritin light chain (FTL) subunit, a critical component of the ferritin protein complex that serves as the primary intracellular iron storage system in eukaryotes. Ferritin is a 24-subunit protein shell (composed of heavy and light chains) capable of storing up to 4,500 iron atoms in a soluble, non-toxic form. The light chain possesses ferroxidase activity that converts toxic Fe²⁺ (ferrous iron) to Fe³⁺ (ferric iron) for safe storage within the protein cavity[@levi2005].

FTL Gene

<div class="infobox infobox-gene">
<table>
<tr><th colspan="2" style="background:#1976D2; color:white;">FTL</th></tr>
<tr><td><strong>Full Name</strong></td><td>Ferritin Light Chain</td></tr>
<tr><td><strong>Gene Symbol</strong></td><td>FTL</td></tr>
<tr><td><strong>Chromosomal Location</strong></td><td>19q13.33</td></tr>
<tr><td><strong>NCBI Gene ID</strong></td><td>2512</td></tr>
<tr><td><strong>OMIM ID</strong></td><td>134790</td></tr>
<tr><td><strong>Ensembl ID</strong></td><td>ENSG00000196954</td></tr>
<tr><td><strong>UniProt ID</strong></td><td>P02792</td></tr>
<tr><td><strong>Protein Family</strong></td><td>Ferritin light chain subunit</td></tr>
<tr><td><strong>Associated Diseases</strong></td><td>Neuroferritinopathy, Alzheimer's Disease, Parkinson's Disease, NBIA</td></tr>
</table>
</div>

Introduction

FTL encodes the ferritin light chain (FTL) subunit, a critical component of the ferritin protein complex that serves as the primary intracellular iron storage system in eukaryotes. Ferritin is a 24-subunit protein shell (composed of heavy and light chains) capable of storing up to 4,500 iron atoms in a soluble, non-toxic form. The light chain possesses ferroxidase activity that converts toxic Fe²⁺ (ferrous iron) to Fe³⁺ (ferric iron) for safe storage within the protein cavity[@levi2005].

Dominant mutations in FTL cause neuroferritinopathy (also called ferritinopathy), a rare form of neurodegeneration with brain iron accumulation (NBIA) characterized by progressive movement disorders and iron deposition in the basal ganglia, cerebellum, and cerebral cortex[@mancuso2020]. Beyond this monogenic disorder, FTL and ferritin function are increasingly recognized as important factors in more common neurodegenerative diseases including Alzheimer's disease (AD), Parkinson's disease (PD), and amyotrophic lateral sclerosis (ALS)[@ward2014].

This comprehensive overview addresses the structure, function, and disease associations of FTL, with particular emphasis on its role in neurodegeneration and therapeutic implications.

Gene Structure and Function

Genomic Organization

The FTL gene is located on chromosome 19q13.33 and encodes the light chain subunit of ferritin. The gene structure has been conserved throughout evolution, reflecting its fundamental role in cellular iron homeostasis.

Key genomic features:

• Chromosomal location: 19q13.33
• Exon count: 4 exons
• Promoter: Contains iron-responsive elements (IREs) for translational regulation
• Alternative splicing: Produces tissue-specific isoforms

Protein Structure

FTL combines with the heavy chain (FTH1) to form the functional ferritin complex:

Structural features:

• Heteropolymer formation: 12 FTL + 12 FTH1 subunits (optimal ratio)
• Hollow shell: 12-nm diameter cavity for iron storage
• Ferroxidase center: Catalytic site for iron oxidation (primarily in heavy chain)
• Iron nucleation sites: Light chain facilitates iron core formation
• Shell stability: Provides structural integrity for the iron core

Molecular Function

Iron Storage and Homeostasis

FTL plays a central role in cellular iron homeostasis:

Iron sequestration:

• Stores up to 4,500 iron atoms per ferritin molecule
• Converts toxic Fe²⁺ to safe Fe³⁺ through ferroxidase activity
• Prevents Fenton reaction-mediated oxidative damage

• Antioxidant defense by sequestering free iron
• Iron availability regulation during stress
• Ferroptosis prevention through iron homeostasis

Ferritinophagy

The autophagic degradation of ferritin, termed ferritinophagy, is a critical process for iron recycling[@wang2014][@khan2019]:

NCOA4-mediated ferritinophagy:

• NCOA4 (Nuclear Receptor Coactivator 4) delivers ferritin to lysosomes
• Iron released during degradation supports cellular needs
• Dysregulated ferritinophagy contributes to iron dysregulation in disease

• Iron availability modulates ferritin degradation
• mTORC1 inhibits ferritinophagy under high iron conditions
• Autophagy regulation affects ferritin turnover

Role in Neurodegenerative Diseases

Neuroferritinopathy (Ferritinopathy)

Neuroferritinopathy is an autosomal dominant disorder caused by FTL mutations, particularly the 460dupA mutation[@curtis2001][@keogh2021]:

Clinical features:

• Movement disorders: Chorea, dystonia, parkinsonism, tremor
• Cognitive decline: Progressive dementia
• Behavioral changes: Personality changes, depression
• Onset: Typically adult-onset (third to sixth decade)

• Iron deposition in basal ganglia on MRI
• Cerebellar and cortical iron accumulation
• "Eye of the tiger" sign similar to other NBIA disorders

Alzheimer's Disease

FTL and ferritin are implicated in AD pathogenesis through multiple mechanisms[@chen2020][@yang2021]:

Amyloid-ferritin relationship:

• Ferritin found in amyloid plaques
• Iron accumulation in AD brain regions
• Ferritin may modulate amyloid-beta toxicity

• Elevated ferritin in cerebrospinal fluid
• Altered iron homeostasis in hippocampus
• Contributes to oxidative stress

• Iron chelation approaches being investigated
• Modulating ferritin expression as potential therapy

Parkinson's Disease

FTL plays important roles in PD pathogenesis[@moore2019][@angelova2019]:

Dopaminergic neuron vulnerability:

• High iron in substantia nigra
• Ferritin expression changes in PD brains
• Iron-induced oxidative stress in dopaminergic neurons

• Ferritin may bind alpha-synuclein
• Iron promotes alpha-synuclein aggregation
• Ferritin dysfunction may contribute toLewy body formation

• Iron chelation shows promise in PD models
• Ferritin modulators under investigation

Amyotrophic Lateral SALS

Iron accumulation is observed in ALS, with FTL potentially involved[@chio2019]:

• Elevated iron in motor cortex
• Ferritin changes in ALS models
• Iron dysregulation may contribute to motor neuron degeneration

Expression Pattern

Brain Region Distribution

FTL is widely expressed in the brain, with highest levels in iron-rich regions[@ward2014]:

| Brain Region | Expression Level | Cell Types |
|--------------|------------------|------------|
| Basal ganglia | Very high | Neurons, glia |
| Substantia nigra | Very high | Dopaminergic neurons |
| Cerebellum | High | Purkinje cells, dentate nucleus |
| Cerebral cortex | Moderate | Pyramidal neurons |
| Hippocampus | Moderate | CA neurons, dentate gyrus |
| Thalamus | Moderate | Various nuclei |

Cellular Localization

Neuronal expression:

• Cytoplasmic distribution
• Colocalization with mitochondria in some cell types
• Axonal and dendritic presence

• Oligodendrocytes: High (myelin production requires iron)
• Microglia: Moderate (iron recycling)
• Astrocytes: Moderate (iron metabolism)

Therapeutic Implications

Current Treatment Strategies

Management of neuroferritinopathy and related disorders includes[@sawicka2024]:

Iron chelation therapy:
| Drug | Mechanism | Status |
|------|-----------|--------|
| Deferoxamine | Iron chelation | Clinical use |
| Deferasirox | Oral iron chelation | Clinical use |
| Deferiprone | Brain-penetrant | Research |

Antioxidant approaches:

• Coenzyme Q10
• Vitamin E
• N-acetylcysteine

• AAV-mediated wild-type FTL delivery
• CRISPR-based gene correction
• RNA interference for mutant alleles

Emerging Therapies

Ferritin modulation:

• Small molecules targeting ferritin expression
• Peptide-based inhibitors of aggregation
• NCOA4 modulators for ferritinophagy

• Dietary iron modulation
• Hepcidin modulators
• Ferroportin targeted approaches

Animal Models

Genetic Models

Transgenic models:

• FTL mutant transgenic mice: Recapitulate iron accumulation
• Knockout models: Embryonic lethal (essential gene)
• Conditional knockouts: Brain-specific phenotypes

• Iron deposition in basal ganglia
• Motor coordination deficits
• Learning and memory impairment

Disease Models

Neuroferritinopathy models:

• 460dupA knock-in mice
• Viral vector-mediated mutant expression

• Ferritin expression changes in APP/α-syn models
• Iron dysregulation studies

Summary

FTL encodes ferritin light chain, a fundamental component of the ferritin protein complex essential for iron storage and cellular protection against oxidative damage. Mutations in FTL cause neuroferritinopathy, a progressive neurodegenerative disorder characterized by movement disorders, cognitive decline, and iron accumulation in the brain.

Beyond monogenic disease, FTL and ferritin function are increasingly recognized as important factors in common neurodegenerative diseases including Alzheimer's disease, Parkinson's disease, and ALS. Iron dysregulation, altered ferritin expression, and impaired ferritinophagy all contribute to disease pathogenesis.

Therapeutic strategies targeting FTL and iron homeostasis include iron chelation, antioxidant therapy, and emerging gene therapy approaches. Understanding FTL function in neurodegeneration continues to inform therapeutic development for these devastating disorders.

See Also

• [FTH1 Gene](/genes/fth1) — Ferritin Heavy Chain
• [Neurodegeneration with Brain Iron Accumulation (NBIA)](/diseases/nbia)
• [Ferritinopathy](/diseases/ferritinopathy)
• [Iron Homeostasis in Neurodegeneration](/mechanisms/iron-homeostasis)
• [Ferroptosis](/mechanisms/ferroptosis)
• [Oxidative Stress Pathway](/mechanisms/oxidative-stress)
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• [Basal Ganglia](/brain-regions/basal-ganglia)
• [Substantia Nigra](/brain-regions/substantia-nigra)

External Links

• [NCBI Gene: FTL](https://www.ncbi.nlm.nih.gov/gene/2512)
• [UniProt: FTL](https://www.uniprot.org/uniprot/P02792)
• [Ensembl: FTL](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000196954)
• [OMIM: FTL](https://omim.org/entry/134790)
• [NBIA Disorders Association](https://nbiadisorders.org/)
• [GeneReviews: FTL-Related Neurodegeneration](https://www.ncbi.nlm.nih.gov/books/NBK1116/)

Pathway Diagram

The following diagram shows the key molecular relationships involving FTL Gene discovered through SciDEX knowledge graph analysis: